跳至主要内容
临床试验/CTRI/2023/09/058150
CTRI/2023/09/058150尚未招募3 期

Evaluation of effectiveness and safety of Nanofat transfer in Androgenetic Alopecia - An interventional study - NI

Varsha M0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patient willing to give written informed consent (Annexure 1a, 1b, 1c)
  • 2. Patients above 18 years of age and either sex
  • 3. Patients with clinically and dermoscopically diagnosed as Androgenetic alopecia
  • 4. Patients with BMI < 40kg/m2

排除标准

  • 1. Patient not willing to give written informed consent
  • 2. Pregnant and lactating women
  • 3. Patients with BMI < 18kg/m2
  • 4. Patients currently suffering from an active autoimmune disease like SLE, Alopecia aerata
  • 5. Patients suffering from any cardiovascular, renal, hematological, pulmonary,
  • gastrointestinal or central nervous system disorders.
  • 6. Patients with any bleeding or clotting disorders or on antiplatelet therapy

研究者

发起方
Varsha M

相似试验